(-)-epigallocatechin 3-gallate multiple interactions ISO LOX (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LOX mRNA CTD PMID:22079256 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LOX mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of LOX mRNA CTD PMID:16079270 17alpha-ethynylestradiol multiple interactions ISO Lox (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LOX mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO LOX (Homo sapiens) 6480464 Estradiol affects the expression of LOX mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO LOX (Homo sapiens) 6480464 Estradiol results in increased expression of LOX mRNA CTD PMID:36142876 17beta-estradiol increases expression ISO Lox (Mus musculus) 6480464 Estradiol results in increased expression of LOX mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO LOX (Homo sapiens) 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of LOX mRNA more ... CTD PMID:20404318 more ... 17beta-estradiol decreases expression ISO LOX (Homo sapiens) 6480464 Estradiol results in decreased expression of LOX mRNA CTD PMID:20106945 and PMID:21632981 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO LOX (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of LOX mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lox (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LOX mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lox (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LOX mRNA CTD PMID:16922920 and PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lox (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LOX mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO LOX (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LOX mRNA CTD PMID:22298810 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lox (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Lox (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Lox (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA CTD PMID:17982090 and PMID:18200517 2-butoxyethanol decreases expression ISO Lox (Mus musculus) 6480464 n-butoxyethanol results in decreased expression of LOX mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Lox (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of LOX mRNA CTD PMID:25172293 3-methylcholanthrene decreases expression ISO Lox (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of LOX mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 and 2-dithiol-3-thione results in increased expression of LOX mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LOX mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO Lox (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LOX mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO Lox (Mus musculus) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Lox (Mus musculus) 6480464 Fenretinide results in increased expression of LOX mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO LOX (Homo sapiens) 6480464 Decitabine results in increased expression of LOX mRNA CTD PMID:17908484 5-aza-2'-deoxycytidine affects expression ISO LOX (Homo sapiens) 6480464 Decitabine affects the expression of LOX mRNA CTD PMID:17194187 5-chloro-7-iodoquinolin-8-ol increases expression ISO LOX (Homo sapiens) 6480464 Clioquinol results in increased expression of LOX mRNA CTD PMID:33034664 5-chloro-7-iodoquinolin-8-ol decreases secretion ISO LOX (Homo sapiens) 6480464 Clioquinol results in decreased secretion of LOX protein CTD PMID:33034664 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of LOX mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of LOX mRNA CTD PMID:19483382 and PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of LOX mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of LOX mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO LOX (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of LOX protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO LOX (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of LOX gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO LOX (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of LOX mRNA CTD PMID:21632981 and PMID:21641981 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of LOX mRNA CTD PMID:16079270 all-trans-retinoic acid decreases expression ISO LOX (Homo sapiens) 6480464 Tretinoin results in decreased expression of LOX mRNA CTD PMID:23724009 all-trans-retinoic acid multiple interactions ISO Lox (Mus musculus) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOX mRNA more ... CTD PMID:30951980 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of LOX mRNA CTD PMID:18355885 and PMID:19483382 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of LOX mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LOX mRNA CTD PMID:16483693 ampicillin increases expression ISO LOX (Homo sapiens) 6480464 Ampicillin results in increased expression of LOX mRNA CTD PMID:21632981 antirheumatic drug increases expression ISO LOX (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of LOX mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO LOX (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of LOX mRNA and aristolochic acid I results in decreased expression of LOX protein CTD PMID:33212167 arsane multiple interactions ISO LOX (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 arsane decreases ubiquitination ISO LOX (Homo sapiens) 6480464 Arsenic results in decreased ubiquitination of LOX protein CTD PMID:35994080 arsenic atom multiple interactions ISO LOX (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 arsenic atom decreases ubiquitination ISO LOX (Homo sapiens) 6480464 Arsenic results in decreased ubiquitination of LOX protein CTD PMID:35994080 arsenite(3-) increases expression ISO LOX (Homo sapiens) 6480464 arsenite results in increased expression of LOX mRNA CTD PMID:23974009 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of LOX mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO Lox (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of LOX mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO LOX (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LOX exon CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO LOX (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of LOX 5' UTR and Benzo(a)pyrene results in decreased methylation of LOX promoter CTD PMID:27901495 benzo[a]pyrene affects expression ISO Lox (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of LOX mRNA CTD PMID:22342234 benzo[a]pyrene decreases expression ISO LOX (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of LOX mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO Lox (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LOX mRNA CTD PMID:21569818 beta-aminopropionitrile decreases activity EXP 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:19524603 beta-aminopropionitrile multiple interactions ISO LOX (Homo sapiens) 6480464 Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] CTD PMID:25044713 beta-aminopropionitrile decreases activity ISO Lox (Mus musculus) 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:22367676 beta-aminopropionitrile decreases activity ISO LOX (Homo sapiens) 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:16023247 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOX mRNA CTD PMID:18164116 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of LOX mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate decreases expression ISO LOX (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of LOX mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate increases expression ISO LOX (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of LOX mRNA CTD PMID:31163220 bisphenol A decreases expression ISO LOX (Homo sapiens) 6480464 bisphenol A results in decreased expression of LOX mRNA CTD PMID:22576693 bisphenol A increases methylation ISO LOX (Homo sapiens) 6480464 bisphenol A results in increased methylation of LOX promoter CTD PMID:31610501 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LOX mRNA CTD PMID:30816183 and PMID:34947998 bisphenol A increases expression ISO Lox (Mus musculus) 6480464 bisphenol A results in increased expression of LOX mRNA CTD PMID:30951980 more ... bisphenol A multiple interactions ISO Lox (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 bisphenol A affects expression ISO LOX (Homo sapiens) 6480464 bisphenol A affects the expression of LOX mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LOX mRNA CTD PMID:25181051 and PMID:33296240 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of LOX mRNA CTD PMID:26496021 Bisphenol B increases expression ISO LOX (Homo sapiens) 6480464 bisphenol B results in increased expression of LOX protein CTD PMID:34186270 bisphenol F multiple interactions ISO Lox (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 bisphenol F increases expression ISO LOX (Homo sapiens) 6480464 bisphenol F results in increased expression of LOX protein CTD PMID:34186270 bisphenol F increases expression ISO Lox (Mus musculus) 6480464 bisphenol F results in increased expression of LOX mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of LOX mRNA CTD PMID:32479839 brucine decreases expression ISO Lox (Mus musculus) 6480464 brucine results in decreased expression of LOX mRNA and brucine results in decreased expression of LOX protein CTD PMID:23933019 brucine decreases expression ISO LOX (Homo sapiens) 6480464 brucine results in decreased expression of LOX mRNA CTD PMID:23933019 cadmium atom affects methylation EXP 6480464 Cadmium affects the methylation of LOX promoter CTD PMID:25741534 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of LOX CTD PMID:19879314 cadmium atom affects expression EXP 6480464 Cadmium affects the expression of LOX CTD PMID:25741534 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of LOX CTD PMID:19879314 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of LOX mRNA CTD PMID:25993096 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein binds to LOX promoter]] CTD PMID:23161664 cadmium dichloride multiple interactions ISO Lox (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA CTD PMID:19840844 calcitriol increases expression ISO LOX (Homo sapiens) 6480464 Calcitriol results in increased expression of LOX mRNA CTD PMID:16002434 carbon nanotube increases expression ISO Lox (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of LOX mRNA CTD PMID:21216836 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of LOX mRNA CTD PMID:30744511 chloroprene increases expression ISO Lox (Mus musculus) 6480464 Chloroprene results in increased expression of LOX mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of LOX mRNA CTD PMID:23125180 ciglitazone multiple interactions ISO LOX (Homo sapiens) 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of LOX mRNA CTD PMID:16197558 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of LOX mRNA CTD PMID:22023808 cisplatin multiple interactions ISO LOX (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of LOX mRNA CTD PMID:20705681 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of LOX mRNA CTD PMID:19483382 clofibrate increases expression ISO Lox (Mus musculus) 6480464 Clofibrate results in increased expression of LOX mRNA CTD PMID:17585979 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of LOX mRNA CTD PMID:18355885 clothianidin increases expression ISO LOX (Homo sapiens) 6480464 clothianidin results in increased expression of LOX mRNA CTD PMID:29044138 cobalt dichloride increases expression ISO LOX (Homo sapiens) 6480464 cobaltous chloride results in increased expression of LOX mRNA and cobaltous chloride results in increased expression of LOX protein CTD PMID:24614111 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of LOX mRNA CTD PMID:23161664 cobalt dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein binds to LOX promoter]] more ... CTD PMID:23161664 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of LOX mRNA CTD PMID:17898221 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 copper atom decreases expression EXP 6480464 Copper results in decreased expression of LOX mRNA CTD PMID:30556269 copper atom multiple interactions ISO Lox (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of LOX mRNA CTD PMID:30556269 copper(0) multiple interactions ISO Lox (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA CTD PMID:15467011 copper(II) chloride increases activity ISO Lox (Mus musculus) 6480464 cupric chloride results in increased activity of LOX protein CTD PMID:22367676 copper(II) chloride multiple interactions ISO LOX (Homo sapiens) 6480464 Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] CTD PMID:25044713 copper(II) chloride increases activity ISO LOX (Homo sapiens) 6480464 cupric chloride results in increased activity of LOX protein CTD PMID:25044713 copper(II) sulfate increases expression ISO LOX (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LOX mRNA CTD PMID:20599845 copper(II) sulfate decreases expression ISO LOX (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of LOX mRNA CTD PMID:19549813 and PMID:20599845 corn oil multiple interactions ISO Lox (Mus musculus) 6480464 Corn Oil results in increased activity of and results in increased cleavage of LOX protein CTD PMID:26240151 crocidolite asbestos decreases expression ISO Lox (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of LOX mRNA CTD PMID:29279043 curcumin multiple interactions ISO Lox (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA] CTD PMID:18200517 cyclosporin A decreases expression ISO LOX (Homo sapiens) 6480464 Cyclosporine results in decreased expression of LOX mRNA CTD PMID:20106945 more ... cytarabine decreases expression ISO LOX (Homo sapiens) 6480464 Cytarabine results in decreased expression of LOX mRNA CTD PMID:21198554 DDT decreases expression EXP 6480464 DDT results in decreased expression of LOX mRNA CTD PMID:30207508 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of LOX mRNA CTD PMID:23640034 deguelin multiple interactions ISO LOX (Homo sapiens) 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] CTD PMID:22745725 desferrioxamine B multiple interactions ISO LOX (Homo sapiens) 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 dexamethasone increases expression ISO Lox (Mus musculus) 6480464 Dexamethasone results in increased expression of LOX mRNA CTD PMID:10926554 and PMID:22733784 dextran sulfate multiple interactions ISO Lox (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOX mRNA and Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of LOX mRNA] CTD PMID:29950665 and PMID:32033881 dextran sulfate increases expression ISO Lox (Mus musculus) 6480464 Dextran Sulfate results in increased expression of LOX mRNA CTD PMID:32033881 and PMID:35093514 diallyl trisulfide multiple interactions ISO LOX (Homo sapiens) 6480464 diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] CTD PMID:28574600 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LOX mRNA CTD PMID:21266533 dicrotophos increases expression ISO LOX (Homo sapiens) 6480464 dicrotophos results in increased expression of LOX mRNA CTD PMID:28302478 dioxygen multiple interactions ISO LOX (Homo sapiens) 6480464 (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] more ... CTD PMID:22745725 more ... dioxygen multiple interactions ISO Lox (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LOX mRNA CTD PMID:30529165 dioxygen increases expression ISO LOX (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of LOX mRNA and Oxygen deficiency results in increased expression of LOX protein CTD PMID:18924134 more ... dioxygen increases activity ISO LOX (Homo sapiens) 6480464 Oxygen deficiency results in increased activity of LOX protein CTD PMID:25044713 dioxygen increases expression ISO Lox (Mus musculus) 6480464 Oxygen deficiency results in increased expression of LOX mRNA and Oxygen deficiency results in increased expression of LOX protein CTD PMID:24614111 diuron decreases expression EXP 6480464 Diuron results in decreased expression of LOX mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO LOX (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO LOX (Homo sapiens) 6480464 LOX protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:32289291 doxorubicin increases expression ISO LOX (Homo sapiens) 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:29803840 doxorubicin decreases expression ISO LOX (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LOX mRNA CTD PMID:22908232 doxorubicin multiple interactions ISO Lox (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of LOX mRNA CTD PMID:21040762 doxorubicin increases expression ISO Lox (Mus musculus) 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:21040762 doxorubicin affects expression ISO Lox (Mus musculus) 6480464 Doxorubicin affects the expression of LOX mRNA CTD PMID:15033991 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LOX mRNA CTD PMID:29391264 ethanol multiple interactions ISO Lox (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOX mRNA CTD PMID:30517762 ethanol decreases expression ISO Lox (Mus musculus) 6480464 Ethanol results in decreased expression of LOX mRNA CTD PMID:34755883 ethanol increases expression ISO LOX (Homo sapiens) 6480464 Ethanol results in increased expression of LOX mRNA CTD PMID:23378141 ethanol multiple interactions ISO LOX (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LOX mRNA CTD PMID:23378141 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of LOX mRNA CTD PMID:30307764 flutamide increases expression EXP 6480464 Flutamide results in increased expression of LOX mRNA CTD PMID:21525395 folic acid multiple interactions ISO LOX (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LOX mRNA CTD PMID:23378141 furan increases expression EXP 6480464 furan results in increased expression of LOX mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of LOX mRNA CTD PMID:33387578 Glutathione ethyl ester decreases expression EXP 6480464 S-ethyl glutathione results in decreased expression of LOX mRNA CTD PMID:19879314 Glutathione ethyl ester decreases activity EXP 6480464 S-ethyl glutathione results in decreased activity of LOX protein CTD PMID:19879314 glycidol increases expression EXP 6480464 glycidol results in increased expression of LOX mRNA CTD PMID:24395379 hemin multiple interactions ISO LOX (Homo sapiens) 6480464 [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 hydrogen peroxide affects expression ISO LOX (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of LOX mRNA CTD PMID:23410634 hydrogen peroxide increases expression ISO LOX (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of LOX mRNA CTD PMID:32949572 hydrogen sulfide increases expression ISO Lox (Mus musculus) 6480464 Hydrogen Sulfide results in increased expression of LOX mRNA CTD PMID:31843631 imipramine affects expression EXP 6480464 Imipramine affects the expression of LOX mRNA CTD PMID:18355885 inulin multiple interactions ISO Lox (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LOX mRNA CTD PMID:36331819 iron atom multiple interactions ISO LOX (Homo sapiens) 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA and [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 iron(0) multiple interactions ISO LOX (Homo sapiens) 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA and [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 isoprenaline increases expression ISO Lox (Mus musculus) 6480464 Isoproterenol results in increased expression of LOX mRNA CTD PMID:20003209 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of LOX mRNA CTD PMID:18355885 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of LOX mRNA CTD PMID:19483382 lead(0) affects expression ISO LOX (Homo sapiens) 6480464 Lead affects the expression of LOX mRNA CTD PMID:28903495 linoleic acid multiple interactions ISO Lox (Mus musculus) 6480464 FADS2 protein inhibits the reaction [Linoleic Acid results in increased activity of LOX protein] and TGFB1 protein promotes the reaction [Linoleic Acid results in increased activity of LOX protein] CTD PMID:26240151 linoleic acid increases activity ISO Lox (Mus musculus) 6480464 Linoleic Acid results in increased activity of LOX protein CTD PMID:26240151 losartan decreases expression EXP 6480464 Losartan results in decreased expression of LOX mRNA CTD PMID:15100363 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of LOX mRNA CTD PMID:28801915 menadione affects expression ISO LOX (Homo sapiens) 6480464 Vitamin K 3 affects the expression of LOX mRNA CTD PMID:23410634 metformin affects expression EXP 6480464 Metformin affects the expression of LOX mRNA CTD PMID:31324951 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of LOX mRNA CTD PMID:30467583 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of LOX mRNA CTD PMID:30744511 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LOX mRNA CTD PMID:25972201 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LOX gene CTD PMID:33148267 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of LOX mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Lox (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOX mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO LOX (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of LOX mRNA CTD PMID:21527772 N-nitrosomorpholine affects expression EXP 6480464 N-nitrosomorpholine affects the expression of LOX mRNA CTD PMID:19716841 naphthalene increases expression ISO Lox (Mus musculus) 6480464 naphthalene results in increased expression of LOX mRNA CTD PMID:18978301 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of LOX mRNA CTD PMID:24136188 nickel atom increases expression ISO Lox (Mus musculus) 6480464 Nickel results in increased expression of LOX mRNA CTD PMID:12540486 nickel dichloride increases expression ISO LOX (Homo sapiens) 6480464 nickel chloride results in increased expression of LOX mRNA CTD PMID:17312168 and PMID:21455298 nickel sulfate increases expression ISO LOX (Homo sapiens) 6480464 nickel sulfate results in increased expression of LOX mRNA CTD PMID:17382205 nickel sulfate decreases expression ISO LOX (Homo sapiens) 6480464 nickel sulfate results in decreased expression of LOX mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of LOX mRNA and nitrofen results in decreased expression of LOX protein CTD PMID:25111273 okadaic acid multiple interactions ISO Lox (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LOX mRNA CTD PMID:19840844 oleic acid increases activity ISO Lox (Mus musculus) 6480464 Oleic Acid results in increased activity of LOX protein CTD PMID:26240151 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of LOX mRNA CTD PMID:19483382 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of LOX mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOX mRNA CTD PMID:25729387 ozone increases expression ISO Lox (Mus musculus) 6480464 Ozone results in increased expression of LOX mRNA CTD PMID:17095637 ozone multiple interactions ISO Lox (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LOX mRNA CTD PMID:34911549 ozone increases expression ISO LOX (Homo sapiens) 6480464 Ozone results in increased expression of LOX mRNA CTD PMID:23033980 paclitaxel multiple interactions ISO LOX (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of LOX mRNA CTD PMID:20705681 paracetamol affects expression ISO Lox (Mus musculus) 6480464 Acetaminophen affects the expression of LOX mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LOX mRNA CTD PMID:17202762 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of LOX mRNA CTD PMID:32680482 pentane-2,3-dione increases expression EXP 6480464 2 and 3-pentanedione results in increased expression of LOX mRNA CTD PMID:25710175 perfluorohexanesulfonic acid increases expression ISO LOX (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in increased expression of LOX mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO LOX (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of LOX mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of LOX mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Lox (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LOX mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of LOX mRNA CTD PMID:16221955 and PMID:19162173 perfluorooctanoic acid increases expression ISO LOX (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of LOX mRNA CTD PMID:25812627 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LOX gene CTD PMID:33148267 phenylmercury acetate increases expression ISO LOX (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of LOX mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO LOX (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO Lox (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LOX mRNA CTD PMID:19840844 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of LOX mRNA CTD PMID:19483382 potassium chromate increases expression ISO LOX (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of LOX mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO LOX (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LOX mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO Lox (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of LOX mRNA CTD PMID:23608068 progesterone increases expression ISO Lox (Mus musculus) 6480464 Progesterone results in increased expression of LOX mRNA CTD PMID:22238285 quercetin decreases expression ISO LOX (Homo sapiens) 6480464 Quercetin results in decreased expression of LOX mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO LOX (Homo sapiens) 6480464 Oxyquinoline results in decreased expression of LOX mRNA CTD PMID:21632981 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of LOX mRNA CTD PMID:16079270 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LOX mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO LOX (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 semicarbazide decreases activity EXP 6480464 carbamylhydrazine results in decreased activity of LOX protein CTD PMID:19524603 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of LOX mRNA CTD PMID:15967596 silicon dioxide decreases expression ISO LOX (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of LOX mRNA CTD PMID:25895662 silver atom decreases expression ISO Lox (Mus musculus) 6480464 Silver results in decreased expression of LOX mRNA CTD PMID:27131904 silver(0) decreases expression ISO Lox (Mus musculus) 6480464 Silver results in decreased expression of LOX mRNA CTD PMID:27131904 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of LOX mRNA CTD PMID:16414398 sodium arsenate increases expression ISO Lox (Mus musculus) 6480464 sodium arsenate results in increased expression of LOX mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO LOX (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO Lox (Mus musculus) 6480464 sodium arsenite results in decreased expression of LOX mRNA CTD PMID:32068019 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of LOX mRNA CTD PMID:25993096 sotorasib multiple interactions ISO LOX (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LOX mRNA CTD PMID:36139627 sulforaphane decreases expression ISO Lox (Mus musculus) 6480464 sulforaphane results in decreased expression of LOX mRNA CTD PMID:30529165 sulindac decreases expression ISO LOX (Homo sapiens) 6480464 Sulindac analog results in decreased expression of LOX mRNA CTD PMID:18924134 sunitinib decreases expression ISO LOX (Homo sapiens) 6480464 Sunitinib results in decreased expression of LOX mRNA CTD PMID:31533062 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of LOX mRNA CTD PMID:15885361 tert-butyl hydroperoxide affects expression ISO LOX (Homo sapiens) 6480464 tert-Butylhydroperoxide affects the expression of LOX mRNA CTD PMID:23410634 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of LOX mRNA CTD PMID:26496021 tetrachloromethane affects expression ISO Lox (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LOX mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO Lox (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in increased expression of LOX mRNA and [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOX mRNA CTD PMID:25827057 and PMID:30517762 tetrachloromethane increases expression ISO Lox (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LOX mRNA CTD PMID:15056808 and PMID:25827057 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of LOX mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LOX mRNA CTD PMID:23411599 titanium dioxide increases expression ISO Lox (Mus musculus) 6480464 titanium dioxide results in increased expression of LOX mRNA CTD PMID:27760801 titanium dioxide multiple interactions ISO Lox (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOX mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO Lox (Mus musculus) 6480464 titanium dioxide results in decreased expression of LOX mRNA CTD PMID:23409001 toluene increases expression EXP 6480464 Toluene results in increased expression of LOX mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOX mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of LOX mRNA CTD PMID:25729387 trametinib multiple interactions ISO LOX (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LOX mRNA CTD PMID:36139627 Trapidil multiple interactions EXP 6480464 Trapidil affects the reaction [PTH protein affects the expression of LOX mRNA] CTD PMID:18635661 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of LOX mRNA CTD PMID:21683754 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LOX mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO Lox (Mus musculus) 6480464 trimellitic anhydride results in increased expression of LOX mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of LOX mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO LOX (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of LOX mRNA CTD PMID:29024780 troglitazone increases expression ISO Lox (Mus musculus) 6480464 troglitazone results in increased expression of LOX mRNA CTD PMID:28973697 urethane decreases expression ISO LOX (Homo sapiens) 6480464 Urethane results in decreased expression of LOX mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of LOX mRNA CTD PMID:15885361 valproic acid increases expression ISO LOX (Homo sapiens) 6480464 Valproic Acid results in increased expression of LOX mRNA CTD PMID:19101580 and PMID:28001369 valproic acid decreases expression ISO LOX (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LOX mRNA CTD PMID:23179753 and PMID:29154799 valproic acid increases expression ISO Lox (Mus musculus) 6480464 Valproic Acid results in increased expression of LOX mRNA CTD PMID:24896083 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LOX mRNA CTD PMID:23034163